SURGERY PARTNERS, INC.
SURGERY PARTNERS, INC.
BRENTWOOD, TN
Loading...
Price History
Market Data
| Market Cap | 1.88B |
| P/E Ratio | - |
| P/B Ratio | 1.10 |
| EPS | -0.61 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 1.87 |
| Currency | USD |
Key Financial Metrics
3.31B
Revenue
-77.90M
Net Income
-0.61
EPS (Diluted)
220.10M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
11.8%
Net Profit Margin
-2.4%
EBITDA
601.80M
Returns & Efficiency
Return on Assets (ROA)
-1.0%
Return on Equity (ROE)
-4.5%
Dividend Yield
-
EPS
-0.61
Financial Health
Total Assets
8.12B
Total Debt
3.74B
Debt to Equity
-
Current Ratio
1.87
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | BRENTWOOD, TN |
| Fiscal Year | 2025 |
Peers
95.80B
P/E: --
95.80B
P/E: --
16.76B
P/E: --
10.34B
P/E: --
1.34B
P/E: --
ARDENT HEALTH, INC.
ARDT
1.34B
P/E: --
Ardent Health, Inc.
ARDT
1.34B
P/E: --
405.84M
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.88B
P/E Ratio (TTM)-
Price to Book1.10
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin11.8%
Net Margin-2.4%
ROE-4.5%
ROA-1.0%
Leverage & Liquidity
Debt to Equity-
Current Ratio1.87
Total Debt$3.74B
Total Assets$8.12B
Stockholders' Equity$1.71B
Income Statement (FY 2025)
Revenue$3.31B
Gross Profit-
Operating Income$389.50M
Net Income$-77.90M
EPS (Diluted)$-0.61
Cash Flow (FY 2025)
Free Cash Flow$220.10M
Cash & Equivalents$239.90M
Revenue Growth6.2%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 310 SEVEN SPRINGS WAY SUITE 500 BRENTWOOD, TN 37027 |
| Phone | 615-234-5900 |
| Incorporated | DE, US |
| EIN | 473620923 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 129.42M |
| Stockholders' Equity | $1.71B |
| Cash & Equivalents | $239.90M |
Recent Filings
View All
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-05-06
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-05
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-05
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-23
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-04-23
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-23
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-16
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-16
Local
144
Proposed Sale Notice
Notice of proposed sale of securities
Filed: 2026-03-16
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-09
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | SURGERY PARTNERS, INC. |
| Ticker | SGRY |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | BRENTWOOD, TN |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.88B |
| Revenue | 3.31B |
| Net Income | -77.90M |
| P/E Ratio | - |
| EPS | -0.61 |
| Net Margin | -2.4% |
| ROE | -4.5% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...